Home/Investors/5AM Ventures

5AM Ventures

Biotech Investor · 3 portfolio companies

Portfolio

3

Combined Value

$770.8M

Focus Areas

8

Top Stage

Phase 1/2

Investment Focus

Neuromuscular Disorders Metabolic Diseases Genetic Disorders Neurology Metabolic Disorders Rare Diseases Oncology Precision Medicine

Portfolio Companies

Company	Stage	Valuation	Focus
Entrada Therapeutics	Phase 1/2	$433.0M	Neuromuscular Disorders, Metabolic Diseases
CAMP4 Therapeutics	Pre-clinical	$259.4M	Neurology, Metabolic Disorders
PMV Pharmaceuticals	Phase 1/2	$78.4M	Oncology, Precision Medicine

Frequent Co-Investors

Atlas Venture1 shared Vertex Pharmaceuticals1 shared RA Capital Management1 shared Fidelity Management & Research Company1 shared Polaris Partners1 shared MPM Capital1 shared Roche Venture Fund1 shared Northpond Ventures1 shared